K-numberK243861
Device namebutterflyBVM
ApplicantCompact Medical, Inc.
Product codeBTM
Device classClass II
Decision dateApr 25, 2025
DecisionSubstantially Equivalent
Regulation868.5915
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The butterflyBVM™ is a single-use, manually operated bag-valve-mask resuscitator designed to deliver emergency pulmonary resuscitation across all patient populations (adults, adolescents, children, infants, and neonates) in both transport/EMS settings and professional healthcare facilities. It features adjustable tidal volume and peak inspiratory pressure dials to allow one device to serve multiple patient sizes.

Technological characteristics

The butterflyBVM uses a bellows design with adjustable tidal volume (30–715 mL) and peak inspiratory pressure (15–60 cmH₂O) dials, compared to the predicate Spur II which comes in three fixed sizes. Both are non-sterile, single-patient-use, prescription-only devices compatible with standard anaesthetic connectors and capable of delivering ≥85% FiO₂ at 15 LPM oxygen flow. The subject device underwent more comprehensive biocompatibility testing (ISO 18562 gas pathway series) than the predicate.

Test standards cited

ISO 10651-4 (operator-powered resuscitators), ISO 5356-1 (conical connectors), ISO 10993 series (biocompatibility), and ISO 18562 series (breathing gas pathway biocompatibility). All tests passed.

Substantial equivalence argument

Both devices share the same intended use (emergency manual ventilation across all patient populations), same regulatory classification (21 CFR 868.5915, Class II), identical operating and storage temperature ranges, and comparable performance in delivered tidal volumes and oxygen concentrations. The butterflyBVM's adjustable dial design replaces the predicate's size-based approach but achieves equivalent clinical function; comparative pressure-limiting testing shows the butterflyBVM actually demonstrates superior repeatability and precision in achieving target pressures. Material biocompatibility testing was more rigorous for the subject device, raising no new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →